Metabolism of prazosin in rat and characterization of metabolites in plasma, urine, faeces, brain and bile using liquid chromatography/mass spectrometry (LC/MS)

References

• Althuis TH, Hess HJ. Synthesis and identification of the major metabolites of prazosin formed in dog and rat. Journal of Medicine and Chemistry 1977; 20(1)146–149
   PubMed Web of Science ®Google Scholar
• Bawaskar HS, Bawaskar PH. Prazosin in management of cardiovascular manifestations of scorpion sting. Lancet 1986; 1(8479)510–511
   PubMed Web of Science ®Google Scholar
• Bawaskar HS, Bawaskar PH. Utility of scorpion antivenin vs. prazosin in the management of severe Mesobuthus tamulus (Indian red scorpion) envenoming at rural setting. Journal of the Association of Physicians of India 2007; 55: 14–21
   PubMedGoogle Scholar
• Constantine J. Analysis of the hypotensive action of prazosin. Prazosin–Evaluation of a new antihypertensive agent, D Cotton. Excerpta Medica, Geneva 1974; 16–36
   Google Scholar
• Daly Christine M, Doyle Michael E, Radkind M, Raskind E, Daniels C. Clinical case series: the use of prazosin for combat-related recurrent nightmares among Operation Iraqi Freedom combat veterans. Military Medicine 2005; 170: 513–515
   PubMed Web of Science ®Google Scholar
• Dick RA, Kwak MK, Sutter TR, Kensler TW. Antioxidative function and substrate specificity of NAD(P)H-dependent alkenal/one oxidoreductase. A new role for leukotriene B4 12-hydroxydehydrogenase/15-oxoprostaglandin 13-reductase. Journal of Biology and Chemistry 2001; 276(44)40803–40810
   PubMed Web of Science ®Google Scholar
• Dierks MR, Jordan JK, Sheehan AH. Prazosin treatment of nightmares related to posttraumatic stress disorder. Annals of Pharmacotherapy 2007; 41(6)1013–1017
   PubMed Web of Science ®Google Scholar
• Erve JCL, Vashishtha SC, DeMaio W, Talaat RE. Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry. Drug Metabolism and Disposition 2007; 35(6)908–916
   PubMed Web of Science ®Google Scholar
• Hieble JP, Ruffolo RR, Jr. The use of alpha-adrenoceptor antagonists in the pharmacological management of benign prostatic hypertrophy: an overview. Pharmacology Research 1996; 33(3)145–160
   Google Scholar
• Kalgutkar AS, Soglia JR. Minimising the potential for metabolic activation in drug discovery. Expert Opinion on Drug Metabolism and Toxicology 2005; 1(1)91–142
   PubMedGoogle Scholar
• Kirkman SK, Zhang M-Y, Horwatt PM, Scatina J. Isolation and identification of bromfenac glucoside from rat bile. Drug Metabolism and Disposition 1998; 26(7)720–723
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Sugihara J, Harigaya S. Mechanism of metabolic cleavage of a furan ring. Drug Metabolism and Disposition 1987; 15(6)877–881
   PubMed Web of Science ®Google Scholar
• Le Fur JM, Labaune JP. Metabolic pathway by cleavage of a furan ring. Xenobiotica 1985; 15(7)567–577
   PubMed Web of Science ®Google Scholar
• Lefkowitz RJ, Hoffman BB. Catecholamines, sympathomimetic drugs, and andrenergic receptor antagonists. Goodman and Gilman's: The Pharmacological Basis of Therapeutics, JG Hardman, LE Limbird, PB Milinoff, RW Ruddon. McGraw-Hill, New York, NY 1996; 199–248
   Google Scholar
• Lindstrom TD, Whitaker GW. Saturation of an a,b-unsaturated ketone: a novel xenobiotic biotransformation in mammals. Xenobiotica 1984; 14(7)503–508
   PubMed Web of Science ®Google Scholar
• Menkes DB, Baraban JM, Aghajanian GK. Prazosin selectively antagonizes neuronal responses mediated by alpha1-adrenoceptors in brain. Naunyn Schmiedebergs Archives in Pharmacology 1981; 317(3)273–275
   PubMed Web of Science ®Google Scholar
• Nassar A-EF, Talaat RE, Kamel AM. The impact of recent innovations in the use of liquid chromatography-mass spectrometry in support of drug metabolism studies: Are we all the way there yet?. Current Opinion in Drug Discovery and Development 2006; 9(1)61–74
   PubMedGoogle Scholar
• Neighbors SM, Soine WH. Identification of phenobarbital N-glucuronides as urinary metabolites of phenobarbital in mice. Drug Metabolism and Disposition 1995; 23(5)548–552
   PubMed Web of Science ®Google Scholar
• Plumb R, Castro-Perez J, Granger J, Beattie I, Joncour K, Wright A. Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry 2004; 18(19)2331–2337
   PubMed Web of Science ®Google Scholar
• Raskind MA, Peskind ER, Hoff DJ, Hart KL, Holmes HA, Warren D, Shofer J, O’Connell J, Taylor F, Gross C, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biological Psychiatry 2007; 61(8)928–934
   PubMed Web of Science ®Google Scholar
• Sayre LM, Engelhart DA, Nadkarni DV, Manoj Babu MK, Flammang AM, McCoy GD. The role of iminium-enamine species in the toxication and detoxication of cyclic tertiary amines 1997; 106–127, NIDA Research Monograph 173(Pharmacokinetics, Metabolism, and Pharmaceutics of Drugs of Abuse)
   Google Scholar
• Staack RF, Varesio E, Hopfgartner G. The combination of liquid chromatography/tandem mass spectrometry and chip-based infusion for improved screening and characterization of drug metabolites. Rapid Communications in Mass Spectrometry 2005; 19(5)618–626
   PubMed Web of Science ®Google Scholar
• Stanaszek WF, Kellerman D, Brogden RN, Romankiewicz JA. Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure. Drugs 1983; 25(4)339–384
   PubMed Web of Science ®Google Scholar
• Stierlin H, Faigle JW, Sallmann A, Kung W, Richter WJ, Kriemler HP, Alt KO, Winkler T. Biotransformation of diclofenac sodium (Voltaren) in animals and in man. I. Isolation and identification of principal metabolites. Xenobiotica 1979; 9(10)601–610
   PubMed Web of Science ®Google Scholar
• Tang W, Stearns RA, Miller RR, Ngui JS, Mathvink RJ, Weber AE, Kwei GY, Strauss JR, Keohane CA, Doss GA, et al. Metabolism of a thiazole benzenesulfonamide derivative, a potent and selective agonist of the human b3-adrenergic receptor, in rats: identification of a novel isethionic acid conjugate. Drug Metabolism and Disposition 2002; 30(7)778–787
   PubMed Web of Science ®Google Scholar
• Taskinen J, Wikberg T, Ottoila P, Kanner L, Lotta T, Pippuri A, Backstrom R. Identification of major metabolites of the catechol-O-methyltransferase-inhibitor nitecapone in human urine. Drug Metabolism and Disposition: The Biological Fate of Chemicals 1991; 19(1)178–183
   PubMed Web of Science ®Google Scholar
• Taylor F, Raskind MA. The a1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder. Journal of Clinical Psychopharmacology 2002; 22(1)82–85
   PubMed Web of Science ®Google Scholar
• Taylor JA, Twomey TM, Schach Von Wittenau M. The metabolic fate of prazosin. Xenobiotica 1977; 7(6)357–364
   PubMed Web of Science ®Google Scholar
• Uetrecht J. Screening for potential of a drug candidate to cause idiosyncratic drug reactions. Drug Discovery Today 2003; 8(18)832–837
   PubMed Web of Science ®Google Scholar
• Watt AP, Mortishire-Smith RJ, Gerhard U, Thomas SR. Metabolite identification in drug discovery. Current Opinion in Drug Discovery and Development 2003; 6(1)57–65
   PubMedGoogle Scholar
• Williams DP, Park BK. Idiosyncratic toxicity: The role of toxicophores and bioactivation. Drug Discovery Today 2003; 8(22)1044–1050
   PubMed Web of Science ®Google Scholar
• Wilson ID, Wade KE, Nicholson JK. Analysis of biological fluids by high-field nuclear magnetic resonance spectroscopy. TrAC, Trends in Analytical Chemistry 1989; 8(10)368–374
   Google Scholar